U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H27N.ClH
Molecular Weight 329.907
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTRIPTYLINE HYDROCHLORIDE

SMILES

Cl.CC(CC1C2=CC=CC=C2CCC3=CC=CC=C13)CN(C)C

InChI

InChIKey=MCWAFEJHLHEFOD-UHFFFAOYSA-N
InChI=1S/C21H27N.ClH/c1-16(15-22(2)3)14-21-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)21;/h4-11,16,21H,12-15H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula C21H27N
Molecular Weight 293.4458
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Butriptyline is a tricyclic antidepressant used in patients with depression associated with anxiety. The drug is supposed to be withdrawn from the market as the last publication about its clinical use is dated by 1988.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
EVADYNE

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
46.5 ng/mL
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
20.3 ng/mL
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
638.7 ng × h/mL
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
536.6 ng × h/mL
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
19.8 h
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
19.3 h
75 mg single, oral
dose: 75 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BUTRIPTYLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
145 mg 1 times / day multiple, oral
Studied dose
Dose: 145 mg, 1 times / day
Route: oral
Route: multiple
Dose: 145 mg, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
75 mg single, oral
Studied dose
Dose: 75 mg
Route: oral
Route: single
Dose: 75 mg
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M
Food Status: UNKNOWN
Sources:
3425 mg single, oral
Overdose
Dose: 3425 mg
Route: oral
Route: single
Dose: 3425 mg
Sources:
healthy
Health Status: healthy
Sex: F
Food Status: UNKNOWN
Sources:
Disc. AE: death...
AEs leading to
discontinuation/dose reduction:
death (grade 5, 1 pt)
Sources:
AEs

AEs

AESignificanceDosePopulation
death grade 5, 1 pt
Disc. AE
3425 mg single, oral
Overdose
Dose: 3425 mg
Route: oral
Route: single
Dose: 3425 mg
Sources:
healthy
Health Status: healthy
Sex: F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Effect of butriptyline on subjective feelings and sleep.
1977-04
Some clinical pharmacological studies with butriptyline, an antidepressive drug.
1977-02
Clinical experience with butriptyline (AY-62014) in the treatment of depressions.
1971
Report of butriptyline hydrochloride (Evadyne) in ambulatory patients.
1971
Psychopharmacological evaluation of a new antidepressant: butriptyline.
1969-12

Sample Use Guides

The daily dosage is between 75 and 150 mg/day.
Route of Administration: Oral
In Vitro Use Guide
Butriptyline exhibited rather potent inhibition of 3H-dopamine uptake in rat corpus striatum with IC50 value in the range 10(-6)-10(-5) M.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:50:43 GMT 2025
Edited
by admin
on Mon Mar 31 18:50:43 GMT 2025
Record UNII
LIJ2H8658W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUTRIPTYLINE HYDROCHLORIDE [MI]
Preferred Name English
BUTRIPTYLINE HYDROCHLORIDE
MART.   MI   USAN   WHO-DD  
USAN  
Official Name English
5H-DIBENZO(A,D)CYCLOHEPTENE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-, HYDROCHLORIDE, (±)-
Systematic Name English
BUTRIPTYLINE HYDROCHLORIDE [USAN]
Common Name English
AY-62014
Code English
BUTRIPTYLINE HCL
Common Name English
(±)-10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-5H-DIBENZO(A,D)CYCLOHEPTENE-5-PROPYLAMINE HYDROCHLORIDE
Systematic Name English
BUTRIPTYLINE HYDROCHLORIDE [MART.]
Common Name English
Butriptyline hydrochloride [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C265
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
Code System Code Type Description
MERCK INDEX
m2805
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
226-983-8
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL2110816
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
PUBCHEM
21771
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
DRUG BANK
DBSALT001091
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
NCI_THESAURUS
C79856
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
FDA UNII
LIJ2H8658W
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
CAS
5585-73-9
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
SMS_ID
100000084843
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID601350507
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
RXCUI
324004
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY RxNorm
EVMPD
SUB00922MIG
Created by admin on Mon Mar 31 18:50:43 GMT 2025 , Edited by admin on Mon Mar 31 18:50:43 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY